...

首页> 外文期刊>European Journal of Cancer Supplements >825 Statistical analysis of survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib (‘Iressa’, ZD1839) in an expanded access program (EAP): preliminary results

【24h】

825 Statistical analysis of survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib (‘Iressa’, ZD1839) in an expanded access program (EAP): preliminary results

机译：825在扩展访问计划（EAP）中，接受吉非替尼（“ Iressa”，ZD1839）治疗的晚期非小细胞肺癌（NSCLC）患者生存率的统计分析：初步结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2003年第5期|共1页
作者
M.Wolf; D.Farina-Sisofo; J.Grous; G.Kennealey; J.Ochs;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 919 Clinically meaningful improvement in disease-related symptoms by gefitinib (‘Iressa’, ZD1839) in patients with advanced non-small-cell lung cancer: relationship between lung cancer subscale scores and radiographic response and survival [J] . J.-Y.Douillard, D.Cella, R.B.Natale, European Journal of Cancer Supplements . 2003,第5期

机译：919吉非替尼（Iressa，ZD1839）对晚期非小细胞肺癌患者的疾病相关症状的临床意义改善：肺癌子量表评分与影像学反应和生存之间的关系
2. Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study. [J] . Janne PA, Gurubhagavatula S, Yeap BY, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2004,第2期

机译：吉非替尼（ZD1839，“ Iressa”）治疗的晚期非小细胞肺癌患者的结局在一项扩展的研究中进行了研究。
3. Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme [J] . Xin-Lin Mu, Long-Yun Li, Xiao-Tong Zhang, BMC Cancer . 2004,第1期

机译：吉非替尼（“ iressa”，zd1839）作为单药治疗在一系列中国晚期非小细胞肺癌患者中的安全性和有效性评估：同情使用计划的经验
4. Effects of Erlotinib after Acquired Resistance to Gefitinib in Advanced Non-small-cell Lung Cancer [C] . Pan Jingjing, Shi Meiqi, Feng Jifeng Biomedical Engineering and Biotechnology (iCBEB), 2012 International Conference on . 2012

机译：吉非替尼耐药对晚期非小细胞肺癌患者的厄洛替尼治疗效果
5. Use of Palliative Radiotherapy Among Metastatic Non-small-cell Lung Cancer (NSCLC) Patients in Puerto Rico [D] . ?Quinones Avila, Valerie 2020

机译：在波多黎各的转移性非小细胞肺癌（NSCLC）患者中使用姑息放射治疗
6. Evaluation of safety and efficacy of gefitinib (iressa zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme [O] . Xin-Lin Mu, Long-Yun Li, Xiao-Tong Zhang, 2004

机译：吉非替尼（ iressazd1839）作为单药治疗在一系列中国晚期非小细胞肺癌患者中的安全性和疗效评估：同情使用计划的经验
7. Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme [O] . 2004

机译：吉非替尼（“ iressa”，zd1839）作为单药治疗在一系列中国晚期非小细胞肺癌患者中的安全性和有效性评估：同情使用计划的经验

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号